hers semaglutide ban Hims & stock falls 25% as FDA curtails compounded GLP-1s Ozempic, Wegovy maker calls out

A Second Lawsuit Complicates the Narrative In the wake of Novo filing suit against Hims, consumer plaintiffs Andrew Donoho and Gloria Ferguson brought a separate case in an Illinois federal court alleging that Hims has misled purchasers by advertising its compounded semaglutide as having the same active ingredient as Ozempic and Wegovy. Unlike Novos patent case, the Illinois complaint does not hinge on whether Hims product contains semaglutide

Glutathione specifically targets oxidative damage and pigmentation

Compounding pharmacies, such as The HCG Institute , can prepare customized formulations of semaglutide tailored to individual patient needs

started to import the substances and set up their own websites

Frequently Asked Questions: Cortisol, Cravings, GLP-1, and Stress Biology 1